Hess Midstream: A Compelling Idea For 2026

Hess Midstream has underperformed recently, down ~8% over the past year with notable weakness in the last three months, but is rated a strong buy based on an 8.8% yield, robust free cash flow and downside protection from minimum volume commitments through 2033. Management is shifting from growth to shareholder returns with distribution growth targeted at ~5% annually through 2027 (covered by cash flow and CPI-linked fee escalators), potential $200m of buybacks next year, and leverage maintained near 3x; a Chevron acquisition remains a potential 2026 catalyst while a standalone base case implies ~12–13% annualized returns.

Analysis

Market structure: HESM’s pivot from growth to shareholder returns (5% distribution CAGR to 2027, CPI-linked fee escalators, MVCs through 2033) benefits income-focused investors and Hess/CVX strategists while pressuring growth-only E&P and lower-yield midstream peers. Minimum volume commitments and predictable fee escalators preserve cashflow so pricing power vs. other midstream operators increases modestly; expect investors to re-rate on distribution safety rather than volume upside. Cross-asset: tighter idiosyncratic credit spreads for HESM and modest downward pressure on broad high-yield energy spreads; options will see elevated IV around any CVX takeover chatter in 2026, commodities largely neutral.

Risk assessment: Tail risks include a failed CVX acquisition process (regulatory/strategic) or a sustained 20-30% fall in underlying volumes from Hess/Chevron that would strain distribution coverage despite MVCs. Immediate (days) — event-driven volatility around buyback announcements; short-term (3–12 months) — distribution coverage and leverage (watch net debt/EBITDA >3.5x); long-term (2026+) — takeover outcomes or sustained buyback accretion driving EPS. Hidden dependencies: Hess upstream capex and CVX capital allocation choices; catalysts are quarterly FCF prints, announced repurchase cadence, and any 2026 CVX bid.

Trade implications: Direct: establish a modest 2–3% core long in HESM at yields >=8.5% targeting 12–13% annualized return or outright takeover premium by 2026; size with stop-loss if distribution coverage falls below 1.0. Pair: long HESM / short Energy Transfer (ET) or AMLP exposure to isolate midstream-idiosyncratic rerating; Options: buy 12–18 month call spreads (low upfront cost) or sell OTM puts funded by selling short-dated calls to monetize elevated yield while capping downside. Rotate into midstream income names and trim pure E&P growth exposure.

Contrarian angles: Market underappreciates buyback accretion — $200m buybacks could reduce float 5–10% and be highly accretive at current prices; consensus may be underweight the probability of a 2026 CVX offer priced at 20–30% premium. The 8% YTD price drop looks potentially overdone vs. stable cashflows; historical parallel: Kinder Morgan’s buyback-driven rerating in mid-cycle. Unintended risk: low inflation could mute CPI escalators and reduce expected fee upside; set sell triggers at leverage >3.5x or coverage <1.0 within two quarters.

Key Decisions for Investors

• Establish a 2–3% long position in HESM (ticker HESM) if yield is >=8.5% or price declines another 5–10%; target hold 12–24 months with a 12–13% annualized return objective and sell if distribution coverage falls below 1.0x or net debt/EBITDA >3.5x.
• Implement a relative-value pair: long HESM vs short Energy Transfer (ET) or short AMLP notional exposure 1:1 to isolate HESM rerating risk; rebalance if spread narrows by 200–300bps or after a confirmed $200m+ buyback announcement.
• Use options to express asymmetric upside: buy a 12–18 month HESM 1:2 call spread (long nearer-dated call, short higher-strike call) sized to 1–2% portfolio risk, or sell 6–9 month 7–8% OTM cash-secured puts if prepared to own at that yield.
• Trigger-based risk control: reduce HESM exposure by 50% within 30 days if quarterly FCF fails to cover the distribution (coverage <1.0) or if net leverage exceeds 3.5x; increase exposure by 50% if buybacks are confirmed at >=$150m annual run-rate and coverage remains >=1.2x.
• Monitor for CVX takeover signals through 2026: scan SEC filings, plaforms/press releases and activist activity quarterly; initiate size increase only after a formal CVX proposal or if market-implied takeover probability (via options skew/IV) rises above 40%.